clinical setting Articles
-
Pilot Validation of a New Wireless Patch System as an Ambulatory, Noninvasive Tool That Measures Gut Myoelectrical Signals: Physiologic and Disease Correlations
Abstract Background and aims: Limited means exist to assess gastrointestinal activity in a noninvasive, objective way that is highly predictive of underlying motility disorders. The aim of this paper is to demonstrate the feasibility of recording myoelectric gastrointestinal activity by cutaneous patches and to correlate myoelectric signals with gastrointestinal function in various clinical ...
-
Antibiotic-resistance and virulence genes in
Enterococcus isolated from tropical recreational watersThe prevalence of enterococci harboring tetracycline- and vancomycin-resistance genes, as well as the enterococcal surface protein (esp) has mostly been determined in clinical settings, but their prevalence in tropical recreational waters remains largely unknown. The present study determined the prevalence of tetM (tetracycline-resistance), vanA and vanB (vancomycin-resistance) in the bacterial ...
-
No-touch Forehead Temperature Measurement in Two Clinical Settings
Background. Healthcare personnel prefer devices that maximize efficiency while minimizing cross-contamination as well as cost. The Caregiver® (Thermomedics, Inc., Miami. FL), a new infrared non-contact forehead thermometer has been developed for clinical professional use. Our objective was to evaluate the clinical accuracy and repeatability of the Caregiver as compared to measurements ...
-
Top 9 Questions about Using NovoSorb BTM in a Clinical Setting
Whether you are a first-time user or an expert in NovoSorb BTM (Biodegradable Temporizing Matrix) for dermal repair and reconstruction, we’re here to answer questions you may have regarding its use in a clinical setting. Below is a list of questions we get asked the most regarding the use of NovoSorb BTM. 1. Can NovoSorb BTM Be Applied with a Graft in a One-Stage Procedure? NovoSorb BTM ...
-
The Future of Quantitative Susceptibility Mapping (QSM) in Clinical Applications
The use of Quantitative Susceptibility Mapping (QSM) is often viewed as incompatible with current standard radiology workflows. Some radiologists or departments may be unaware of its existence or purpose. Despite the skepticism surrounding its viability in a clinical setting, QSM shows great potential in a wide range of clinical applications, particularly for biomarker detection and ...
-
The evolution of photoplethysmography (PPG) within smart devices
As a technology, photoplethysmography (PPG) has been explored for almost a century, but it is only in the last few years that it has had a broader application beyond specialised medical settings. That has generally been driven by the evolution of smartphones, smartwatches and even smaller wearable devices such as smart rings. PPG is most commonly used in pulse oximetry in clinical settings ...
By Sky Labs
-
Our ryze training and CDISC support services - all you need to know
Whether you’re a regular ryze user or are new to the platform, at some point you might need some help navigating your way around. From product training on the ryze platform to support with a specific element of the CDISC standards, we’re here to help. As soon as you start working with us, you’ll have your own account manager. Someone you can turn to for product support by phone ...
By Formedix
-
Development Trends And Potential Challenges of PROTACs
PROTAC technology has been in development for more than 20 years. PROTAC proof-of-concept studies date back to 2001, when Crews' team tested the possibility of artificially induced intracellular protein degradation with a peptide that was too large in molecular weight and required cells to penetrate the peptide to improve cell permeability. The discovery of the first small molecule PROTAC and the ...
-
A new mindset for combination product development
In this article, Asmita Khanolkar, Senior Director, Cambridge Pharma, at SMC, outlines the latest trends in combination product development to overcome some of the current challenges of high dose/viscosity/volume delivery. Based on the learnings from the covid-19 pandemic, it is time to emphasise the changing mindset towards a forward- looking design and development process for combination ...
-
The Power of Digital Pathology: Why Labs Everywhere Should Make the Switch
Pathology as it is practiced today in labs around the world is not all that different from the pathology of the 19th century. The microscope has changed relatively little since then, and Hematoxylin and Eosin (H&E) stained slides remain the bread and butter of the pathologist. Yet it is not for lack of technological development; in recent years, digital pathology whole slide scanners, digital ...
-
Dyve Biosciences enrolls first patient in gout trial
Dyve Biosciences announced today that it enrolled its first patient in the Phase 2 clinical study of its DYV-700 topically administered therapeutic for acute gout treatment. Thousand Oaks, Calif.–based Dyve won FDA clearance to begin the Targets Phase 2 trial in December 2019. The double-blind, placebo-controlled, randomized clinical trial is set to evaluate the efficacy of DYV-700 in ...
-
Enhancing Healthcare Security: The Role of Door Frame Metal Detectors in Hospitals and Clinics
Enhancing Healthcare Security: The Role of Door Frame Metal Detectors in Hospitals and Clinics The safety and security of patients, healthcare professionals, and visitors are paramount in hospitals and clinics. With the evolving landscape of security threats, the implementation of robust security measures is essential to ensure a secure environment conducive to healing and care. Door frame metal ...
-
5 FAQs to Know about Using NovoSorb BTM
Whether you are a first-time user or an expert in NovoSorb® BTM (Biodegradable Temporizing Matrix) for dermal repair and reconstruction, we’re here to answer questions you may have regarding its use in a clinical setting. Below you’ll find answers to the questions we get asked the most regarding the use of NovoSorb BTM. 1. How Long Does It Take for BTM to Fully Integrate with the ...
-
Nano-Flow Cytometry: A Revolutionary Tool for Biomedical Research
Nano-flow cytometry is a revolutionary technology that has the potential to transform early disease detection and diagnosis. Nano-flow cytometers are able to detect and analyze individual nanoparticles, including extracellular vesicles and viruses, with high sensitivity and accuracy. This makes them ideal for detecting diseases at their earliest stages, when they are most treatable. How does ...
-
Targeted Region Sequencing in Human Disease Studies and Clinical Care
Introduction to target region sequencing Since the introduction of Sanger sequencing in 1977, genetic sequencing has been greatly improved with costs simultaneously falling. With the ability to rapidly produce large volumes of sequencing data, next-generation sequencing (NGS) enables researchers to obtain whole genome or targeted regions of samples. Targeted region sequencing is preferred by ...
By CD Genomics
-
Computer Vision-Based Digital Biomarkers Could Enable Faster and More Accurate In Vivo Assessment of Disease
At Recursion, we are working to decode biology and industrialize drug discovery. We have successfully executed over 82 million phenomic experiments and inferred over 179 billion biological relationships in our quest to identify promising novel therapeutic approaches. Now, we are extending our industrialized approach to petabytes of pre-clinical in vivo studies. Digitalizing in vivo studies ...
By Recursion
-
Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access
Objective: Patients with end stage renal failure who require haemodialysis suffer morbidity and mortality due to vascular access. Bioengineered human acellular vessels (HAVs) may provide a haemodialysis access option with fewer complications than other grafts. In a prospective phase II trial from 2012 to 2014 (NCT01744418), HAVs were implanted into 40 haemodialysis patients at three sites in ...
-
Cell Transplantation Promising for Treatment of Biliary Diseases
Biliary disease is a term used to describe diseases that affect the biliary system, which can result in inflammation, fibrosis, bile duct destruction, and eventually liver failure. It also frequently leads to secondary infections and chronic irritation, such as bile duct stones, which can lead to malignant tumors. There is currently no cure for biliary tract diseases other than liver ...
-
8 reasons why you should use Pheezee
Pheezee Pheezee is a pocket size wearable device by startoon labs that can be worn by the patient while doing physiotherapy sessions. The device gives a real time biofeedback of range of motion and electromyogram (EMG) of the recruited muscle. The device connects wirelessly to an android phone/tablet to display reports. The physiotherapist can see session wise, week wise, month wise and ...
-
Virtual Triage: Do more questions lead to better patient outcomes?
One of the common misconceptions related to virtual triage / symptom checker tools is that the more questions the system asks, the more accurate the list of possible conditions / triage level recommendations will be and so, overall, the conclusion is that it is more thorough and, therefore, a better tool. If you are looking to provide your patients with a symptom checker/triage tool or are a ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you